top of page
DNA 4.png
odeo (1).png

Testing for RET

Welcome to our webinar series on RET. We are excited to share with you the latest research and information on RET-driven cancers. Select a webinar below to learn more about the featured speaker and watch a 1-hr webinar. 


Molecular Testing in Thyroid Cancer: Why It Matters

Lori J. Wirth, MD


Genetic and Genomic Testing in Thyroid Cancer: Why, when, who and how?

Bryan McIver, MD, PhD

Cohen-Ezra head shot.jpg

Molecular Testing in Thyroid Cancer: Emerging Biomarkers RET and NTRK

Ezra E.W. Cohen, MD, FRCPSC, FASCO


Thyroid Carcinomas with RET?  You bet!

Justin Bishop MD

2016-03 UCSAP Lester D R Thompson.jpg

Selected Thyroid Follicular Lesions

Lester D. R. Thompson, MD

RET Fusions in Thyroid Cancer:
Prevalence, Histologic Features, Detection

Yuri E. Nikiforov, MD, PhD

Testing for RET is provided by Lighthouse, a Celerity Biosciences Subsidy, and Funded by Loxo Oncology at Lilly

bottom of page